Ovarian Cancer | Shannon N Westin, MD, MPH

published 8 months ago by Dr Neil Love

The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 1: Integration of PARP-Inhibitor Maintenance Therapy into the Management of Newly Diagnosed Ovarian Cancer — Dr Westin. CME information and select publications

more episodes from Research To Practice | Oncology Videos